{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T20:47:54Z","timestamp":1698353274997},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1993,10,1]],"date-time":"1993-10-01T00:00:00Z","timestamp":749433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[1993,10]]},"DOI":"10.1007\/bf00852530","type":"journal-article","created":{"date-parts":[[2004,12,23]],"date-time":"2004-12-23T23:39:46Z","timestamp":1103845186000},"page":"515-519","source":"Crossref","is-referenced-by-count":4,"title":["Prostacyclin in diarrhoea-associated haemolytic uraemic syndrome"],"prefix":"10.1007","volume":"7","author":[{"given":"C. M.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"Lote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","volume":"ii","author":"W St C Symmers","year":"1952","unstructured":"Symmers W St C (1952) Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). BMJ (ii): 897?903","journal-title":"BMJ"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ki.1988.17","volume":"33","author":"MDS Walters","year":"1988","unstructured":"Walters MDS, Levin M, Smith C, Nokes TJC, Hardisty RM, Dillon MJ, Barratt TM (1988) Intravascular platelet activation in the hemolytic uremic syndrome. Kidney Int 33: 107?115","journal-title":"Kidney Int"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(78)91573-8","volume":"II","author":"G Remuzzi","year":"1978","unstructured":"Remuzzi G, Marchesi D, Mecca G, Misiani R, Livio M, Gaetano G de, Donati MB (1978) Haemolytic uraemic syndrome. Deficiency of plasma factor(s) regulating prostacyclin activity? Lancet II: 871?872","journal-title":"Lancet"},{"key":"CR4","first-page":"645","volume":"21","author":"B T\ufffdnshoff","year":"1990","unstructured":"T\ufffdnshoff B, Momper R, Schweer H, Scharer K, Seyberth HW (1990) Increased formation of thromboxane A2 and prostacyclin in anaphylactoid purpura. Adv Prostaglandin Thromboxane Leukotriene Res 21: 645?648","journal-title":"Adv Prostaglandin Thromboxane Leukotriene Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.292.6527.1037","volume":"292","author":"IAG Reilly","year":"1986","unstructured":"Reilly IAG, Roy L, Fitzgerald GA (1986) Biosynthesis of thromboxanc in patients with systemic sclerosis and Raynaud's phenomenon. BMJ 292: 1037?1039","journal-title":"BMJ"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198404263101701","volume":"310","author":"gA Fitzgerald","year":"1984","unstructured":"Fitzgerald gA, Smith B, Pederson AK, Brash AR (1984) Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med 310: 1065?1068","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/01.HYP.12.6.530","volume":"12","author":"RJ Gryglewski","year":"1988","unstructured":"Gryglewski RJ, Botting RM, Vane JR (1988) Mediators produced by the endothelial cell. Hypertension 12: 530?548","journal-title":"Hypertension"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00852859","volume":"5","author":"CM Taylor","year":"1991","unstructured":"Taylor CM, Milford DV, White RHR (1991) A plea for standardized terminology within the haemolytic uraemic syndromes. Pediatric Nephrol 5: 97","journal-title":"Pediatric Nephrol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0952-3278(89)90134-8","volume":"36","author":"CJ Lote","year":"1989","unstructured":"Lote CJ, Haylor J (1989) Eicosanoids in renal function. Prostaglandins Leukot Essent Fatty Acids 36: 203?217","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"CR10","first-page":"295","volume":"21","author":"E Granstrom","year":"1990","unstructured":"Granstrom E, Kindahl H (1990) A critical approach to eicosanoid assay. Adv Prostaglandin Thromboxane Leukotriene Res 21: 295?302","journal-title":"Adv Prostaglandin Thromboxane Leukotriene Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90905-8","volume":"81","author":"F Catella","year":"1986","unstructured":"Catella F, Nowak J, Fitzgerald GA (1986) Measurement of renal and non-renal eicosanoid synthesis. Am J Med 81: 23?29","journal-title":"Am J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0952-3278(91)90168-5","volume":"43","author":"A Hornych","year":"1991","unstructured":"Hornych A, Forette F, Bariety J, Krief C, Aumont J, Paris M (1991) The influence of age on renal prostaglandin synthesis in man. Prostaglandins Leukot Essent Fatty Acids 43: 191?195","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/cs0700141","volume":"70","author":"J Haylor","year":"1986","unstructured":"Haylor J, Lote CJ, Thewles A (1986) The effect of sodium bicarbonate on the flow dependency of urinary PGE excretion in man. Clin Sci 70: 141?145","journal-title":"Clin Sci"},{"issue":"Suppl","key":"CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-6980(84)90300-9","volume":"27","author":"M Fichman","year":"1984","unstructured":"Fichman M, Nadler J (1984) Lack of correlation of urinary 6-Keto-PGF1-alpha with urine volume, in contrast to volume-related increases in urinary PGE in polyuric states. Prostaglandins 27 (Suppl): 55","journal-title":"Prostaglandins"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0262-1746(84)90074-X","volume":"16","author":"JY Jeremy","year":"1984","unstructured":"Jeremy JY, Mikhailidis DP, Dandona P (1984) The rat urinary bladder produces prostacyclin as well as other prostaglandins. Prostaglandins Leukotr Med 16: 235?248","journal-title":"Prostaglandins Leukotr Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0022-5347(17)44109-7","volume":"137","author":"DP Mikhailidis","year":"1987","unstructured":"Mikhailidis DP, Jeremy JY, Dandona P (1987) Urinary bladder prostanoids. Their synthesis, function and possible role in the pathogenesis and treatment of disease. J Urol 137: 577?582","journal-title":"J Urol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0090-6980(86)90134-6","volume":"32","author":"PG Baer","year":"1986","unstructured":"Baer PG, Cagen LM, Nasjletti A (1986) 6-Keto-PGF1-alpha is not added to urine during passage through the rat urinary bladder in vivo. Prostaglandins 32: 311?316","journal-title":"Prostaglandins"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(77)91655-5","volume":"I","author":"S Moncada","year":"1977","unstructured":"Moncada S, Higgs EA, Vane JR (1977) Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet I: 18?20","journal-title":"Lancet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3476(85)80243-2","volume":"106","author":"MJ Stuart","year":"1985","unstructured":"Stuart MJ, Spitzer RE, Walenga RW, Boone S (1985) Prostanoids in hemolytic uremic syndrome. J Pediatr 106: 936?939","journal-title":"J Pediatr"},{"key":"CR20","first-page":"193","volume":"25","author":"S Turi","year":"1986","unstructured":"Turi S, Beattie TJ, Belch JVF, Murphy AV (1986) Disturbances of prostacyclin metabolism in children with hemolytic uremic syndrome and in first degree relatives. Clin Nephrol 25: 193?198","journal-title":"Clin Nephrol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/adc.66.10.1231","volume":"66","author":"AN Alam","year":"1991","unstructured":"Alam AN, Abdal NM, Wahed MA, Rao B, Kawser CAQ, Hoque M, Rahaman MM (1991) Prostacyclin concentrations in hemolytic uraemic syndrome after acute shigellosis in children. Arch Dis Child 66: 1231?1234","journal-title":"Arch Dis Child"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/adc.67.11.1412-b","volume":"67","author":"CM Taylor","year":"1992","unstructured":"Taylor CM, Lote CJ (1992) Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis. Arch Dis Child 67: 1412?1413","journal-title":"Arch Dis Child"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ki.1990.96","volume":"37","author":"B T\ufffdnshoff","year":"1990","unstructured":"T\ufffdnshoff B, Momper R, Kuhl PG, Schweer H, Scharer K, Seyberth HW (1990) Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney Int 37: 1134?1141","journal-title":"Kidney Int"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0272-6386(12)80542-7","volume":"20","author":"M Noris","year":"1992","unstructured":"Noris M, Benigni A, Siegler R, Gaspari F, Casiraghi F, Mancini ML, Remuzzi G (1992) Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation. Am J Kidney Dis 20: 144?149","journal-title":"Am J Kidney Dis"},{"key":"CR25","first-page":"13","volume":"3","author":"DA Chamone","year":"1982","unstructured":"Chamone DA, Proesmans WC, Monnens LA, Binda ki Muaka P, Vermylen JG (1982) Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome. Int J Pediatr Neprhol 3: 13?16","journal-title":"Int J Pediatr Neprhol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/adc.58.9.703","volume":"58","author":"M Levin","year":"1983","unstructured":"Levin M, Eikon KB, Nikes TJC, Buckle AM, Dillon MJ, Hardisty RM, Barratt TM (1983) Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome. Arch Dis Child 58: 703?708","journal-title":"Arch Dis Child"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-3476(87)80344-X","volume":"111","author":"N Schlegel","year":"1987","unstructured":"Schlegel N, Maclouf J, Loirat C, Drouet L, Marotte R, Scarabin PY, Mathieu H (1987) Absence of a plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome. J Pediatr 111: 71?77","journal-title":"J Pediatr"},{"key":"CR28","first-page":"165","volume":"144","author":"RL Siegler","year":"1986","unstructured":"Siegler RL, Smith JB, Lynch MB, Mohammed SF (1986) In vitro prostacyclin production in the hemolytic uremic syndrome. West J Med 144: 165?168","journal-title":"West J Med"},{"key":"CR29","first-page":"37","volume":"149","author":"RL Siegler","year":"1988","unstructured":"Siegler RL, Smith JB, Lynch MB, Mohammed SF (1988) Prostacyclin production following in vitro mixing of normal with hemolyticuremic syndrome serum. West J Med 149: 37?39","journal-title":"West J Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0882-4010(88)90024-1","volume":"5","author":"H Karch","year":"1988","unstructured":"Karch H, Bitzan M, Pietsch R, Stenger K-O, Wulffen H von, Heesemann J, Dusing R (1988) Purified verotoxins ofEscherichia coli 0157:H7 decrease prostacyclin synthesis by endothelial cells. Microb Pathog 5: 215?221","journal-title":"Microb Pathog"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(77)90437-8","volume":"II","author":"G Remuzzi","year":"1977","unstructured":"Remuzzi G, Mecca G, Caenaghi AE, Donati MB, Gactano G de (1977) Prostacyclin-like activity and bleeding in renal failure. Lancet II: 1195?1197","journal-title":"Lancet"},{"key":"CR32","first-page":"355","volume-title":"Hemolytic uremic syndrome: thrombotic thrombocytopenic purpura","author":"CM Taylor","year":"1992","unstructured":"Taylor CM, Powell HR (1992) Oxygen-derived free radicals in the pathogenesis of the hemolytic uremic syndrome. In: Kaplan B, Trompeter B, Moake J (eds) Hemolytic uremic syndrome: thrombotic thrombocytopenic purpura. Dekker, New York, pp 355?372"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00858677","volume":"2","author":"C Loirat","year":"1988","unstructured":"Loirat C, Sonsino E, Hinglais N, Jais JP, Landais P, Fermanian J (1988) Treatment of the childhood haemolytic uraemic syndrome with plasma. Pediatr Nephrol 2: 279?285","journal-title":"Pediatr Nephrol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00858678","volume":"2","author":"BR Cole","year":"1988","unstructured":"Cole BR (1988) Plasma infusion therapy in hemolytic uremic syndrome: is it warranted? Pediatr Nephrol 2: 286?287","journal-title":"Pediatr Nephrol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/adc.59.5.401","volume":"59","author":"HR Powell","year":"1984","unstructured":"Powell HR, McCredie DA, Taylor CM, Burke JR, Walker RG (1984) Vitamin E treatment of haemolytic uraemic syndrome. Arch Dis Child 59: 401?404","journal-title":"Arch Dis Child"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/bmj.283.6289.470","volume":"283","author":"TJ Beattie","year":"1981","unstructured":"Beattie TJ, Murphy AV, Willoughby MLN, Belch JJF (1981) Prostacyclin infusion in haemolytic-uraemic syndrome of children. BMJ 283: 470","journal-title":"BMJ"},{"key":"CR37","first-page":"C31","volume":"5","author":"SK Parida","year":"1991","unstructured":"Parida SK, Milford DV, Taylor CM (1991) Pilot study of Epoprostenol (PGI2) treatment in diarrhoea-associated haemolytic uraemic syndrome (abstract). Pediatr Nephrol 5: C31","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00852530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00852530\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00852530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T17:07:18Z","timestamp":1556298438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00852530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,10]]}},"alternative-id":["BF00852530"],"URL":"https:\/\/doi.org\/10.1007\/bf00852530","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,10]]}}}